Your browser doesn't support javascript.
loading
Underdosed generic specialty medications: A prescription for patient harm?
Okuda, Darin T; Burgess, Katy W; Moog, Tatum M; Patel, Mahi A.
Afiliación
  • Okuda DT; The University of Texas Southwestern Medical Center, Department of Neurology, Neuroinnovation Program, Multiple Sclerosis & Neuroimmunology Imaging Program, Dallas, TX, USA; The University of Texas Southwestern Medical Center, Peter O'Donnell Jr. Brain Institute, Dallas, Texas USA. Electronic ad
  • Burgess KW; The University of Texas Southwestern Medical Center, Department of Neurology, Neuroinnovation Program, Multiple Sclerosis & Neuroimmunology Imaging Program, Dallas, TX, USA; The University of Texas Southwestern Medical Center, Peter O'Donnell Jr. Brain Institute, Dallas, Texas USA.
  • Moog TM; The University of Texas Southwestern Medical Center, Department of Neurology, Neuroinnovation Program, Multiple Sclerosis & Neuroimmunology Imaging Program, Dallas, TX, USA; The University of Texas Southwestern Medical Center, Peter O'Donnell Jr. Brain Institute, Dallas, Texas USA.
  • Patel MA; The University of Texas Southwestern Medical Center, Department of Neurology, Neuroinnovation Program, Multiple Sclerosis & Neuroimmunology Imaging Program, Dallas, TX, USA; The University of Texas Southwestern Medical Center, Peter O'Donnell Jr. Brain Institute, Dallas, Texas USA.
Mult Scler Relat Disord ; 88: 105760, 2024 Aug.
Article en En | MEDLINE | ID: mdl-38991404
ABSTRACT
The use of generic specialty medications amongst individuals with multiple sclerosis (MS) has expanded due to an increase in the number of available agents. We describe a woman who was denied continued use of brand name teriflunomide (AubagioⓇ), despite being clinically stable for 2.5 years, and switched to generic teriflunomide. She experienced a significant spinal cord exacerbation within a few months of starting treatment. We analyzed 3 generic teriflunomide agents, including the one used for treatment, in addition to AubagioⓇ. The generic teriflunomide used by our patient contained 55.5 % content of the labeled amount, well below U.S. FDA specifications.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Toluidinas / Crotonatos / Medicamentos Genéricos / Hidroxibutiratos / Nitrilos Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: Mult Scler Relat Disord Año: 2024 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Toluidinas / Crotonatos / Medicamentos Genéricos / Hidroxibutiratos / Nitrilos Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: Mult Scler Relat Disord Año: 2024 Tipo del documento: Article Pais de publicación: Países Bajos